Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_assertion type Assertion NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_head.
- NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_assertion description "[It has been hypothesised that individuals with homozygous deletion of the GSTM1 and/or GSTT1 gene may have lower detoxification capacity towards genotoxic agents therefore those individuals may be at increased risk of myelodysplastic syndrome which is a preleukemic condition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_provenance.
- NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_assertion evidence source_evidence_literature NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_provenance.
- NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_assertion SIO_000772 18493876 NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_provenance.
- NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_assertion wasDerivedFrom gad-20130706 NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_provenance.
- NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_assertion wasGeneratedBy ECO_0000203 NP64751.RA05YwNK32jw7m7it64RsoYgljAKtGhqYfmHMn2fznl_8130_provenance.